You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company said it will use the net proceeds to redeem the outstanding $500 million aggregate principal amount of senior notes maturing in January 2018.
The ratings agency also assigned a Negative Rating Watch to the firm's notes offering, noting it will resolve this notation as more details of the offering become available.
The firm plans to use the funds to repay outstanding debts and for general corporate purposes.
The firm has not disclosed the amount it is seeking, but said it plans to use the funds to repay outstanding debts and for general corporate purposes.
The company said it will use most of the proceeds to redeem the outstanding $900 million principal amount of its 1.30 percent senior notes due 2017.
Fitch has given the two-year senior notes offering a BBB rating with a Stable outlook.
The 10-year notes were rated BBB by Fitch, which also declared the ratings outlook Stable.
The firm sold three series of senior notes and will use proceeds to repay other outstanding debt.
The firm will use the proceeds along with cash on hand to redeem notes that mature in August.
The Salt Lake City-based company said it would use the $18.4 million in expected gross aggregate proceeds for product pipeline development and customer growth.
The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.
According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.
The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.
In Nature this week: the largest known collection of human genetic variants, and more.